Arunjyoti Bio Ventures Limited (ABVL.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-1144.1%

-₹44.06

vs ₹4.22 price

Levered DCF

-₹56.93

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

—

Rating

D+

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	-26.79×	-133.8×	-311.49×	591.38×	169.71×	207.88×	31.27×	87.11×
P/B	4.23×	7.47×	61.52×	32.88×	4.74×	7.26×	1.76×	1.92×
P/S	4.38×	8.68×	5.31×	40.08×	3.19×	2.56×	0.45×	0.91×
EV / EBITDA	539.12×	50.54×	56.74×	615.85×	122.92×	135.62×	16.69×	77.92×
Gross margin	13.0%	59.0%	58.4%	13.8%	3.0%	12.7%	16.7%	15.5%
Operating margin	-11.1%	7.1%	3.9%	9.5%	-6.8%	1.8%	1.8%	1.1%
Net margin	-16.3%	-6.5%	-1.7%	6.7%	1.9%	1.2%	1.4%	1.0%
Current ratio	0.43×	2.8×	2.24×	3.64×	11.67×	1.16×	1.09×	1.07×
Debt / equity	0.78×	0.81×	29.1×	15.25×	0×	0×	0×	0×
Interest coverage	-1.51×	0.76×	0.38×	22.33×	-190.37×	16.41×	687.67×	296.33×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	-15.8%	-5.6%	-19.7%	5.5%	2.8%	3.5%	5.6%	2.2%
Return on invested capital	-5.3%	3.3%	0.4%	0.4%	-7.5%	3.7%	5.7%	2.4%
Return on assets	-8.4%	-3.1%	-0.6%	0.3%	2.7%	1.5%	1.8%	0.7%
Free cash flow yield	4.6%	-1.8%	-15.7%	-46.3%	-8.2%	-2.2%	23.4%	-80.2%
Earnings yield	-3.7%	-0.8%	-0.3%	0.2%	0.6%	0.5%	3.2%	1.1%
Enterprise value	₹1.4B	₹2.7B	₹1.6B	₹1B	₹94.8M	₹133.1M	₹21.8M	₹30.4M
Net debt / EBITDA	83.1×	4.84×	18.2×	195.08×	-0.1×	-8.24×	-8.54×	-8.87×
Cash conversion cycle (days)	34	136	158	381	64	24	4	48